Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, Winkelmayer WC, Ellenberg SS, Cifelli D, Madigan R, Young A, Angeletti M, Wingard RL, Kahn C, Nissenson AR, Maddux FW, Abbott KC, Landis JR.

J Am Soc Nephrol. 2019 May;30(5):890-903. doi: 10.1681/ASN.2018090945. Epub 2019 Apr 18.

PMID:
31000566
2.

Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.

Kapoian T, Khalil S, O'Mara NB, Brink DM, Daugirdas JT.

Am J Nephrol. 2019;49(5):368-376. doi: 10.1159/000499438. Epub 2019 Apr 2.

3.
5.

Consumption of phosphorus-containing beverages as a potential aggravating cause of Mesoamerican nephropathy.

Daugirdas JT, Ball JT.

Hemodial Int. 2018 Jul;22(3):421-422. doi: 10.1111/hdi.12678. No abstract available.

PMID:
30141570
6.

Changes in Total Protein Concentration Due to Fluid Removal During and Shortly after Hemodialysis.

Daugirdas JT.

Am J Nephrol. 2018;48(2):118-126. doi: 10.1159/000491935. Epub 2018 Aug 15.

PMID:
30110671
7.

Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Orlandi PF, Fujii N, Roy J, Chen HY, Lee Hamm L, Sondheimer JH, He J, Fischer MJ, Rincon-Choles H, Krishnan G, Townsend R, Shafi T, Hsu CY, Kusek JW, Daugirdas JT, Feldman HI; CRIC Study Investigators.

BMC Nephrol. 2018 Jun 26;19(1):150. doi: 10.1186/s12882-018-0951-0.

8.

Creatinine generation from kinetic modeling with or without postdialysis serum creatinine measurement: results from the HEMO study.

Daugirdas JT, Depner TA.

Nephrol Dial Transplant. 2018 Jan 1;33(1):187. doi: 10.1093/ndt/gfx320. No abstract available.

PMID:
29149291
9.

Iron and anemia in chronic kidney disease: New treatments changing old paradigms.

Daugirdas JT.

Hemodial Int. 2017 Jun;21 Suppl 1:S3-S5. doi: 10.1111/hdi.12569. No abstract available.

PMID:
28449417
10.

Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease.

Kalantar-Zadeh K, Crowley ST, Beddhu S, Chen JLT, Daugirdas JT, Goldfarb DS, Jin A, Kovesdy CP, Leehey DJ, Moradi H, Navaneethan SD, Norris KC, Obi Y, O'Hare A, Shafi T, Streja E, Unruh ML, Vachharajani TJ, Weisbord S, Rhee CM.

Semin Dial. 2017 May;30(3):251-261. doi: 10.1111/sdi.12601. Epub 2017 Apr 18. Review.

11.

Creatinine generation from kinetic modeling with or without postdialysis serum creatinine measurement: results from the HEMO study.

Daugirdas JT, Depner TA.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1926-1933. doi: 10.1093/ndt/gfx038.

12.

Frank Gotch.

Daugirdas JT, Keen ML, Levin NW.

Hemodial Int. 2017 Apr;21(2):153-154. doi: 10.1111/hdi.12551. No abstract available.

PMID:
28371202
13.

Prediction equation for calculating residual kidney urea clearance using urine collections for different hemodialysis treatment frequencies and interdialytic intervals.

Obi Y, Kalantar-Zadeh K, Streja E, Daugirdas JT.

Nephrol Dial Transplant. 2018 Mar 1;33(3):530-539. doi: 10.1093/ndt/gfw473.

14.
15.

Scaling Hemodialysis Dose: Kt Over What?

Daugirdas JT.

Am J Kidney Dis. 2017 Mar;69(3):331-333. doi: 10.1053/j.ajkd.2016.11.011. No abstract available.

PMID:
28236880
16.

Assessing the Adequacy of Small Solute Clearance for Various Dialysis Modalities, with Inclusion of Residual Native Kidney Function.

Chin AI, Depner TA, Daugirdas JT.

Semin Dial. 2017 May;30(3):235-240. doi: 10.1111/sdi.12584. Epub 2017 Feb 14. Review.

PMID:
28194810
17.

Hemodialysis Treatment Time: As Important as it Seems?

Daugirdas JT.

Semin Dial. 2017 Mar;30(2):93-98. doi: 10.1111/sdi.12575. Epub 2017 Jan 16. Review.

PMID:
28092113
18.

Hemodialysis Ultrafiltration Rate Targets Should Be Scaled to Body Surface Area Rather than to Body Weight.

Daugirdas JT, Schneditz D.

Semin Dial. 2017 Jan;30(1):15-19. doi: 10.1111/sdi.12563.

PMID:
28043081
19.

Solute solver 'what if' module for modeling urea kinetics.

Daugirdas JT.

Nephrol Dial Transplant. 2016 Nov;31(11):1934-1937. Epub 2016 Sep 1.

PMID:
27587603
20.
21.
22.
23.

We Underdialyze Women and Smaller Patients.

Daugirdas JT.

Semin Dial. 2016 Jul;29(4):303-5. doi: 10.1111/sdi.12510. Epub 2016 May 7.

PMID:
27153931
24.

Teaching renal physiology in the 21st century: focus on acid-base physiology.

Leehey DJ, Daugirdas JT.

Clin Kidney J. 2016 Apr;9(2):330-3. doi: 10.1093/ckj/sfv138. Epub 2015 Dec 24.

25.

The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.

Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW; Frequent Hemodialysis Network (FHN) Trial Group.

Blood Purif. 2016;41(4):277-86. doi: 10.1159/000441966. Epub 2016 Jan 21.

26.

Theoretical basis for and improvement of Daugirdas' second generation formula for single-pool Kt/V.

Sternby J, Daugirdas JT.

Int J Artif Organs. 2015 Dec;38(12):632-7. doi: 10.5301/ijao.5000456. Epub 2015 Dec 24.

PMID:
26743181
27.

Lower cardiovascular mortality with high-volume hemodiafiltration: a cool effect?

Daugirdas JT.

Nephrol Dial Transplant. 2016 Jun;31(6):853-6. doi: 10.1093/ndt/gfv412. Epub 2015 Dec 19. No abstract available.

PMID:
26687900
28.

Long-Term Effects of Frequent In-Center Hemodialysis.

Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T; Frequent Hemodialysis Network (FHN) Trials Group.

J Am Soc Nephrol. 2016 Jun;27(6):1830-6. doi: 10.1681/ASN.2015040426. Epub 2015 Oct 14.

29.

You're Not Big--You're Just Tall, That's All!

Daugirdas JT.

J Am Soc Nephrol. 2016 Feb;27(2):339-41. doi: 10.1681/ASN.2015070816. Epub 2015 Oct 1. No abstract available.

30.

Removal of Phosphorus by Hemodialysis.

Daugirdas JT.

Semin Dial. 2015 Nov-Dec;28(6):620-3. doi: 10.1111/sdi.12439. Epub 2015 Sep 11. Review.

PMID:
26358370
31.

Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.

Daugirdas JT.

Kidney Int. 2015 Sep;88(3):466-73. doi: 10.1038/ki.2015.204. Epub 2015 Jul 15. Review.

PMID:
26176827
32.

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.

Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2015 Sep;66(3):459-68. doi: 10.1053/j.ajkd.2015.02.331. Epub 2015 Apr 8.

33.

Measuring intradialytic hypotension to improve quality of care.

Daugirdas JT.

J Am Soc Nephrol. 2015 Mar;26(3):512-4. doi: 10.1681/ASN.2014090860. Epub 2014 Sep 30. No abstract available.

34.

Knowing what we do and doing what we should: quality assurance in hemodialysis.

Alquist M, Bosch JP, Barth C, Combe C, Daugirdas JT, Hegbrant JB, Martin G, McIntyre CW, O'Donoghue DJ, Rodriguez HJ, Santoro A, Tattersall JE, Vantard G, Van Wyck DB, Canaud B.

Nephron Clin Pract. 2014;126(3):135-43. doi: 10.1159/000361050. Epub 2014 Apr 15.

PMID:
24751758
35.

Dialysis dosing for chronic hemodialysis: beyond Kt/V.

Daugirdas JT.

Semin Dial. 2014 Mar;27(2):98-107.

PMID:
24738145
36.

Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial.

Chan CT, Chertow GM, Daugirdas JT, Greene TH, Kotanko P, Larive B, Pierratos A, Stokes JB; Frequent Hemodialysis Network Daily Trial Group.

Nephrol Dial Transplant. 2014 Jan;29(1):168-78. doi: 10.1093/ndt/gft212. Epub 2013 Sep 26.

37.

Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2106-16. doi: 10.2215/CJN.03280313. Epub 2013 Aug 22.

38.

Bioimpedance technology and optimal fluid management.

Daugirdas JT.

Am J Kidney Dis. 2013 Jun;61(6):861-4. doi: 10.1053/j.ajkd.2013.03.004. No abstract available.

PMID:
23684491
39.

Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.

Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, Kurella Tamura M, Suri RS, Levin NW, Kliger AS; Frequent Hemodialysis Network Trial Group.

Nephrol Dial Transplant. 2013 Jul;28(7):1888-98. doi: 10.1093/ndt/gfs593. Epub 2013 Jan 27.

40.

Effect of frequent hemodialysis on residual kidney function.

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS; FHN Trial Group.

Kidney Int. 2013 May;83(5):949-58. doi: 10.1038/ki.2012.457. Epub 2013 Jan 23.

41.

Dialysis time, survival, and dose-targeting bias.

Daugirdas JT.

Kidney Int. 2013 Jan;83(1):9-13. doi: 10.1038/ki.2012.365.

42.

Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality.

Ramirez SP, Kapke A, Port FK, Wolfe RA, Saran R, Pearson J, Hirth RA, Messana JM, Daugirdas JT.

Clin J Am Soc Nephrol. 2012 Dec;7(12):1977-87. doi: 10.2215/CJN.00390112. Epub 2012 Sep 13.

43.

Potential importance of low-sodium bread and breakfast cereal to a reduced sodium diet.

Daugirdas JT.

J Ren Nutr. 2013 Jan;23(1):1-3. doi: 10.1053/j.jrn.2012.03.002. Epub 2012 May 26. Review.

PMID:
22633991
44.

Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia.

Daugirdas JT, Bernardo AA.

Kidney Int. 2012 Jul;82(2):147-57. doi: 10.1038/ki.2012.130. Epub 2012 May 16. Review.

45.

Improved equation for estimating single-pool Kt/V at higher dialysis frequencies.

Daugirdas JT, Leypoldt JK, Akonur A, Greene T, Depner TA; FHN Trial Group.

Nephrol Dial Transplant. 2013 Aug;28(8):2156-60. doi: 10.1093/ndt/gfs115. Epub 2012 May 4.

46.

The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial.

Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM; FHN Trial Group.

Kidney Int. 2012 Jul;82(1):90-9. doi: 10.1038/ki.2012.75. Epub 2012 Mar 28.

47.

Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.

Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, Kendrick CA, James SH, Miller BW, Schulman G, Salusky IB, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group.

J Am Soc Nephrol. 2012 Apr;23(4):727-38. doi: 10.1681/ASN.2011070688. Epub 2012 Feb 23.

48.

Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S; Frequent Hemodialysis Network (FHN) Trial Group.

Circ Cardiovasc Imaging. 2012 Mar;5(2):251-61. doi: 10.1161/CIRCIMAGING.111.969923. Epub 2012 Feb 23.

49.

Hemodialysis adequacy and biocompatibility.

Daugirdas JT.

Semin Dial. 2011 Sep-Oct;24(5):508-9. doi: 10.1111/j.1525-139X.2011.00984.x. No abstract available.

PMID:
21999738
50.

Is there a minimal amount of time a patient should be dialyzed regardless of measured KT/V?

Daugirdas JT.

Semin Dial. 2011 Jul-Aug;24(4):423-5. doi: 10.1111/j.1525-139X.2011.00941.x. Epub 2011 Jul 31. No abstract available.

PMID:
21801229

Supplemental Content

Loading ...
Support Center